FDA approves new indications for pembrolizumabJuly 1, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Can an app guide cancer treatment decisions during the pandemic?June 9, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerCOVID-19 UpdatesGastroenterologyGenitourinary CancerGynecologic Cancer
‘A good and peaceful death’: Cancer hospice during the pandemicJune 5, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Germline testing in advanced cancer can lead to targeted treatmentJune 3, 2020Mixed TopicsBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Video coaching may relieve anxiety and distress for long-distance cancer caregiversMay 14, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
ASCO goes ahead online, as conference center is used as hospitalMay 11, 2020Mixed TopicsBreast CancerCNS/Brain CancerCOVID-19 UpdatesGastroenterologyGenitourinary CancerGynecologic Cancer
Want to keep cancer patients and providers safe during the pandemic? Here’s howApril 20, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Merkel cell carcinoma management undergoes revolutionMarch 11, 2020Nonmelanoma Skin CancerRare Diseases
SCC survival remains poor in epidermolysis bullosaFebruary 25, 2020Rare DiseasesNonmelanoma Skin Cancer
FDA approves first treatment for advanced epithelioid sarcomaJanuary 24, 2020Sarcoma & GISTRare Diseases
Expedited review programs not shortening drug developmentJanuary 14, 2020Practice ManagementRare Diseases
Efficacy of postvenetoclax therapy may depend on prior agent exposure in CLLDecember 10, 2019Leukemia, Myelodysplasia, TransplantationRare Diseases
Myeloma patients over age 70 can benefit from auto-HC transplantDecember 7, 2019Lymphoma & Plasma Cell DisordersRare Diseases
High complete response rate seen with novel CAR-T for myelomaDecember 7, 2019Immuno-oncologyImmunotherapyLymphoma & Plasma Cell DisordersRare Diseases
